CORT Corcept Therapeutics Incorporated

$75.05

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated discovers, develops, and markets drugs for the treatment of severe metabolic, cancer, and psychiatric disorders in the United States. The company is headquartered in Menlo Park, California.

Website: https://www.corcept.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1088856
Address
149 COMMONWEALTH DRIVE, MENLO PARK, CA, US
Valuation
Market Cap
$6.57B
P/E Ratio
50.60
PEG Ratio
0.61
Price to Book
9.66
Performance
EPS
$1.23
Dividend Yield
—
Profit Margin
20.90%
ROE
23.80%
Technicals
50D MA
$65.29
200D MA
$50.97
52W High
$117.33
52W Low
$20.84
Fundamentals
Shares Outstanding
106M
Target Price
$143.25
Beta
0.14

CORT EPS Estimates vs Actual

● Estimated
● Actual

CORT News & Sentiment

Nov 06, 2025 • Benzinga SOMEWHAT-BULLISH
Peering Into Corcept Therapeutics Inc's Recent Short Interest - Corcept Therapeutics ( NASDAQ:CORT )
Corcept Therapeutics Inc's ( NYSE:CORT ) short interest as a percent of float has fallen 3.81% since its last report. According to exchange reported data, there are now 10.24 million shares sold short, which is 13.13% of all regular shares that are available for trading.
Nov 05, 2025 • Zacks Commentary NEUTRAL
Corcept Q3 Earnings & Revenues Lag Estimates, '25 View Cut, Stock Down
CORT's third-quarter earnings and sales miss estimate. The company cuts guidance despite a 14% year-over-year rise in revenues. Stock falls.
Nov 04, 2025 • Zacks Commentary NEUTRAL
Corcept Therapeutics ( CORT ) Q3 Earnings and Revenues Miss Estimates
Corcept (CORT) delivered earnings and revenue surprises of -11.11% and -5.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Nov 04, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Should Invesco S&P SmallCap Momentum ETF ( XSMO ) Be on Your Investing Radar?
Style Box ETF report for ...
Oct 29, 2025 • Zacks Commentary NEUTRAL
NewAmsterdam Pharma Company N.V. ( NAMS ) Expected to Beat Earnings Estimates: Should You Buy?
NewAmsterdam Pharma Company N.V. (NAMS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Oct 22, 2025 • Zacks Commentary NEUTRAL
Analysts Estimate Corcept Therapeutics ( CORT ) to Report a Decline in Earnings: What to Look Out for
Corcept (CORT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sentiment Snapshot

Average Sentiment Score:

0.217
50 articles with scored sentiment

Overall Sentiment:

Bullish

CORT Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
0.1 Surprise
  • Reported EPS: $0.29
  • Estimate: $0.19
  • Whisper: —
  • Surprise %: 55.6%
May 05, 2025
Mar 31, 2025 (Post market)
0.03 Surprise
  • Reported EPS: $0.17
  • Estimate: $0.14
  • Whisper: —
  • Surprise %: 18.8%
Feb 26, 2025
Dec 31, 2024 (Post market)
-0.16 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.42
  • Whisper: —
  • Surprise %: -38.6%
Oct 30, 2024
Sep 30, 2024 (Post market)
0.13 Surprise
  • Reported EPS: $0.41
  • Estimate: $0.28
  • Whisper: —
  • Surprise %: 46.4%
Jul 29, 2024
Jun 30, 2024 (Post market)
0.09 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.23
  • Whisper: —
  • Surprise %: 39.1%
May 01, 2024
Mar 31, 2024 (Post market)
0.03 Surprise
  • Reported EPS: $0.25
  • Estimate: $0.22
  • Whisper: —
  • Surprise %: 13.6%
Feb 15, 2024
Dec 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.26
  • Whisper: —
  • Surprise %: 7.7%
Nov 01, 2023
Sep 30, 2023 (Post market)
0.06 Surprise
  • Reported EPS: $0.28
  • Estimate: $0.22
  • Whisper: —
  • Surprise %: 27.3%
Aug 02, 2023
Jun 30, 2023 (Post market)
0.1 Surprise
  • Reported EPS: $0.25
  • Estimate: $0.15
  • Whisper: —
  • Surprise %: 66.7%

Financials